Last updated on August 2019

Evaluation of SPN-812 ER High Dose in Adolescents With ADHD


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
  • Age: Between 12 - 17 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Healthy male or female subjects, 12-17 years of age, inclusive.
  • Diagnosis of ADHD according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM V), confirmed with the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID).
  • Attention Deficit/Hyperactivity Disorder Rating Scale-V, Home Version: Adolescent, Investigator Administered and Scored (ADHD-RS-V) score of at least 28.
  • CGI-S score of at least 4 at screening.
  • Weight of at least 35 kg.
  • Free of medication for the treatment of ADHD for at least one week prior to randomization and agreement to remain so throughout the study.

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.